Analysis of the pulmonary tomographic pattern by the b.1.1.7 and p.1 variants of the sars-cov-2 virus
International Journal of Development Research
Analysis of the pulmonary tomographic pattern by the b.1.1.7 and p.1 variants of the sars-cov-2 virus
Received 11th January, 2022; Received in revised form 26th February, 2022; Accepted 14th March, 2022; Published online 27th April, 2022
Copyright © 2022, Beatriz Amaral Costa Savino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The SARS-CoV-2 virus has undergone several genetic mutations, which culminated in multiple waves of disease transmission. Computed tomography (CT) of the chest may be a diagnostic alternative complementary to RT-PCR to assess pulmonary involvement and assist in the therapeutic approach. To analyze the pulmonary tomographic patterns in the epidemic peaks of COVID-19 caused by the B.1.1.7 and P.1 variants of the SARS-CoV-2 virus. Cross-sectional, descriptive, analytical and retrospective study through the evaluation of 360chest CT scans of patients with COVID-19 in two epidemic peaks of the disease of April–September 2020(B.1.1.7) and October 2020–March 2021(P.1) in an area of the Brazilian Amazon. Were included patients >18 years old of both sexes. The pattern and degree of pulmonary involvement, distribution of lesions, affected segments and other CT findings were evaluated. Gender (p=0.289) and age group (p=0.314) did not vary significantly between periods. In the first, 70.6% had pulmonary involvement10-25% and in the second,43.3%. The presence of interlobular septa thickening was significantly observed in the first epidemic peak (81.9%) (p=0.002). Prevalence of women and age between 45-60 years. All had ground-glass lesions and the typical pattern of involvement prevailed in both analyses. The Alpha variant presented a higher degree of pulmonary involvement in relation to the Gamma variant.